References
- The World Health OrganizationThe Top Ten Causes of Death Fact Sheet 20122015 Available from: http:/www.who.int/mediacentre/factsheets/fs310/en/Accessed February 1, 2015
- FusterVMearnsBMThe CVD paradox: mortality vs prevalenceNat Rev Cardiol200961166919851344
- BautersCMeuriceTHamonMMcFaddenELablancheJMBertrandMEMechanisms and prevention of restenosis: from experimental models to clinical practiceCardiovasc Res19963168358468759238
- NabelEGBraunwaldEA tale of coronary artery diease and myocardial infarctionN Engl J Med20123661546322216842
- TamburinoCLatibAvan GeunsRJContemporary practice and technical aspects in coronary intervention with bioresorbable scaffold a European perspective.pdfEuroIntervention201510116
- AlfonsoFByrneRARiveroFKastratiACurrent treatment of in-stent restenosisJ Am Coll Cardiol201463242659267324632282
- MoliternoDJHealing achilles – sirolimus versus paclitaxelN Engl J Med2005353772472716105991
- McFaddenEPStabileERegarELate thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapyLancet200436494441519152115500897
- TsimikasSDrug-eluting stents and late adverse clinical outcomes lessons learned, lessons awaitedJ Am Coll Cardiol200647102112211516697332
- GrewePHDenekeTMachraouiABarmeyerJMüllerKMAcute and chronic tissue response to coronary stent implantation: pathologic findings in human specimenJ Am Coll Cardiol200035115716310636274
- WindeckerSKolhPAlfonsoF2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Eur Heart J201435372541261925173339
- MoriceMCUrbanPGreeneSSchulerGChevalierBWhy are we still using coronary bare-metal stents?J Am Coll Cardiol201361101122112323333139
- AminAPSpertusJACohenDJUse of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practiceArch Intern Med2012172151145115222777536
- PfistererMBrunner-La RoccaHPRickenbacherPBASKETLong-term benefit-risk balance of drug-eluting vs bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKETEur Heart J2009301162419033260
- TuJVBowenJChiuMEffectiveness and safety of drug-eluting stents in OntarioN Engl J Med2007357141393140217914040
- GreenhalghJHockenhullJRaoNDundarYDicksonRCBagustADrug-eluting stents versus bare metal stents for angina or acute coronary syndromesCochrane Database Syst Rev20105CD00458720464732
- MenownIBNoadRGarciaEJMeredithIThe platinum chromium element stent platform: from alloy, to design, to clinical practiceAdv Ther201027312914120437213
- O’BrienBJStinsonJSLarsenSREppihimerMJCarrollWMA platinum-chromium steel for cardiovascular stentsBiomaterials201031143755376120181394
- TurcoMAThe integrity® bare-metal stent made by continuous sinusoid technologyExpert Rev Med Devices20118330330621542702
- KastratiAMehilliJDirschingerJIntracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trialCirculation2001103232816282111401938
- GotmanICharacteristics of metals used in implantsJ Endourol19971163833899440845
- MesserRLMickalonisJLewisJBInteractions between stainless steel, shear stress, and monocytesJ Biomed Mater Res A200887122923518092353
- AlloccoDJJacoskiMVHuibregtseBMickleyTDawkinsKDCoronary stents platinum chromium stent series – the TAXUS™ Element™ (ION™), PROMUS Element™ and OMEGA™ stentsIntervent Cardiol201162134141
- KastratiASchömigADirschingerJIncreased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery diseaseCirculation2000101212478248310831521
- BennettJDuboisCA novel platinum chromium everolimus-eluting stent for the treatment of coronary artery diseaseBiologics20137114915923818756
- SoucyNVFeyginJMTunstallRStrut tissue coverage and endothelial cell coverage: a comparison between bare metal stent platforms and platinum chromium stents with and without everolimus-eluting coatingEuroIntervention20106563063721044918
- WangJCCarriéDMasottiMPrimary endpoint results of the OMEGA Study: one-year clinical outcomes after implantation of a novel platinum chromium bare metal stentCardiovasc Revasc Med2015162656925576273
- StoneGWTeirsteinPSMeredithITPLATINUM Trial InvestigatorsA prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a prospective, randomized, multicenter trial to assess an everolimus-eluting coronary stent system [PROMUS Element] for the treatment of up to Two de Novo CorJ Am Coll Cardiol201157161700170821470815
- ParkKWKangS-HKangH-JA randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based Zotarolimus-Eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of corJ Am Coll Cardiol201463252805281624814486
- SketchMHBallMRutherfordBPopmaJJRussellCKereiakesDJEvaluation of the medtronic (Driver) cobalt-chromium alloy coronary stent systemAm J Cardiol200595181215619386
- NefHMMöllmannHWeberMCobalt-chrome MULTI-LINK VISION-stent implantation in diabetics and complex lesions: results from the DaVinci-registryClin Res Cardiol2009981173173719697076
- FajadetJWijnsWLaarmanGJLong-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II studyEuroIntervention20106556256721044908
- IshiharaSMawadMEOgataKHistopathologic findings in human cerebral aneurysms embolized with platinum coils: report of two cases and review of the literatureAJNR Am J Neuroradiol200223697097412063226
- EppihimerMJSushkovaNGrimsbyJLImpact of stent surface on thrombogenicity and vascular healing: a comparative analysis of metallic and polymeric surfacesCirc Cardiovasc Interv20136437037723899869
- VirmaniRFarbAGuagliumiGKolodgieFDDrug-eluting stents: caution and concerns for long-term outcomeCoron Artery Dis200415631331815346088
- FinnAVNakazawaGJonerMVascular responses to drug eluting stents: importance of delayed healingArterioscler Thromb Vasc Biol20072771500151017510464
- SmitsPCHofmaSTogniMAbluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trialLancet2013381986765166023374650
- NatsuakiMKozumaKMorimotoTNEXT InvestigatorsBiodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trialJ Am Coll Cardiol201362318119023684673
- SCAARSwedish Coronary Angiography and Angioplasty Registry2015 Available from: http://www.ucr.uu.se/swedeheart/index.php/forskning-scaar/in-english/stent-reportsAccessed April 1, 2015
- TamburinoCCapodannoDErglisAOne-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS element European post-approval surveillance study (TE-PROVE)EuroIntervention201510111261126625572023
- WilliamsPDMamasMAFraserDGHow serious an adverse event is longitudinal stent deformation? Incidence and severityExpert Rev Med Devices20129544945123116069
- HanrattyCGWalshSJLongitudinal compression: a “new” complication with modern coronary stent platforms – time to think beyond deliverability?EuroIntervention20117787287721970984
- MamasMAWilliamsPDLongitudinal stent deformation: insights on mechanisms, treatments and outcomes from the Food and Drug Administration Manufacturer and User Facility Device Experience databaseEuroIntervention20128219620422381263
- ArnousSShakhshirNWiperAIncidence, and mechanisms of longitudinal stent deformation (LSD) associated with biomatrix, resolute, element and xience stents: angiographic and case-by-case review of 1,800 PCIsCatheter Cardiovasc Interv2014
- LeibundgutGGickMTomaALongitudinal compression of the platinum-chromium everolimus-eluting stent during coronary implantation: predisposing mechanical properties, incidence, and predictors in a large patient cohortCatheter Cardiovasc Interv2013815206214
- PrabhuSSchikorrTMahmoudTJacobsJPotgieterASimontonCEngineering assessment of the longitudinal compression behaviour of contemporary coronary stentsEuroIntervention20128227528122057097
- OrmistonJAWebberBWebsterMWIStent longitudinal integrity bench insights into a clinical problemJACC Cardiovasc Interv20114121310131722136972
- KereiakesDJPopmaJJCannonLALongitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trialsEuroIntervention20128218719522445912
- ThomasMRBirkemeyerRSchwimmbeckPOne-year outcomes in 1,010 unselected patients treated with the PROMUS element everolimus-eluting stent: the multicentre PROMUS element European Post-Approval Surveillance StudyEuroIntervention201510111267127125631367
- OrmistonJAWebberBUbodBWhiteJWebsterMWIStent longitudinal strength assessed using point compression: insights from a second-generation, clinically related bench testCirc Cardiovasc Interv201371626924368821